Document:

Form of Substitute Option Certificate

 Exhibit 10.13 
 Final Form 
 SUBSTITUTE OPTION CERTIFICATE 
 Optionee: 
 This Option
and any securities issued upon exercise of this Option are subject to restrictions on voting and transfer and requirements of sale and other provisions as set forth in the Stockholders Agreement among CRC Health Group, Inc. and certain investors,
dated as of February 6, 2006, as amended from time to time (the “Stockholders Agreement”). This Option and any securities issued upon exercise of this Option constitute Management Shares as defined therein. 
 CRC HEALTH GROUP, INC. 
 STOCK OPTION

 CERTIFICATE 
 This stock
option (the “Agreement”) is granted by CRC Health Group, Inc. (f/k/a CRCA Holdings, Inc.), a Delaware corporation (the “Company”), to the Optionee, pursuant to the Company’s 2006 Executive Incentive Plan, as amended from
time to time (the “Plan”). For the purpose of this Agreement, the “Grant Date” shall mean February 6, 2006. 
  

	1.	Grant of Option. This certificate evidences the grant by the Company on the Grant Date to the Optionee of an option to purchase (the “Option”), in whole or in part,
on the terms provided herein and in the Plan, [            ] Units at $[            ] per Unit. 

 Each “Unit” consists of 9 shares of Class A Common Stock of the Company, par value $.001 per share, and 1 share of Class L Common Stock of
the Company, par value $.001 per share, subject to adjustment as provided in the Plan. The Option evidenced by this certificate is not intended to qualify as an incentive stock option under Section 422 of the Internal Revenue Code (the
“Code”). This Option is granted in substitution of an option (which option is hereby deemed cancelled) held by the Optionee in CRC Health Corporation (f/k/a CRC Health Group, Inc.) (“Rollover Option”). Except as permitted in
Section 409A Rollover Law and expressly provided in this Agreement, the terms of the Rollover Option are deemed incorporated into this Option; it being understood, that the exercise price and the number of shares may be adjusted as permitted
under Section 409A Law. The Option shall be subject to the terms of the plan that previously governed the Rollover Option immediately prior to the date hereof, and to the terms of any other agreement previously governing the Rollover Option for
which this Option is substituted to the extent required by Section 409A Rollover Law, and will also be governed by the Plan, as applicable, and the Stockholders Agreement, in each case to the extent consistent with Section 409A Rollover
Law. 
  

	2.	Vesting. The Option is fully vested. 

  

	3.	 Exercise of Option. Each election to exercise this Option shall be subject to the terms and conditions of the Plan and shall be in writing, signed by the
Optionee or by his or her executor or administrator or by the person or persons to whom this Option is transferred by will or the applicable laws of descent and distribution (the “Legal Representative”), 

  

 -1- 

	 	 
and made pursuant to and in accordance with the terms and conditions set forth in the Plan. The latest date on which this Option may be exercised (the
“Final Exercise Date”) is the latest date upon which the Rollover Option was exercisable, subject to earlier termination in accordance with the terms and provisions of the Plan and this Agreement. 

  

	4.	Representations and Warranties of Optionee.  

 Optionee represents and warrants that: 
  

	 	(a)	Authorization. Optionee has full legal capacity, power, and authority to execute and deliver this Agreement and to perform Optionee’s obligations hereunder. This
Agreement has been duly executed and delivered by Optionee and is the legal, valid, and binding obligation of Optionee enforceable against Optionee in accordance with the terms hereof. 

  

	 	(b)	No Conflicts. The execution, delivery, and performance by Optionee of this Agreement and the consummation by Optionee of the transactions contemplated hereby will not, with
or without the giving of notice or lapse of time, or both (i) violate any provision of law, statute, rule or regulation to which Optionee is subject, (ii) violate any order, judgment or decree applicable to Optionee, or (iii) conflict
with, or result in a breach of default under, any term or condition of any agreement or other instrument to which Optionee is a party or by which Optionee is bound. 

  

	 	(c)	No Other Agreements. Except as provided by this Agreement, the Stockholders Agreement and the Plan, Optionee is not a party to or subject to any agreement or arrangement with
respect to the voting or transfer of this Option or the shares of common stock issued upon exercise hereof. 

  

	 	(d)	Thorough Review, etc. Optionee has thoroughly reviewed the Plan and this Agreement in their entirety. Optionee has had an opportunity to obtain the advice of counsel (other
than counsel to the Company or its Affiliates) prior to executing this Agreement, and fully understands all provisions of the Plan and this Agreement. 

  

	 	(e)	Investment Intent. The Optionee is acquiring the Stock solely for the Optionee’s own account for investment and not with a view to or for sale in connection with
any distribution of the Stock or any portion thereof and not with any present intention of selling, offering to sell or otherwise disposing of or distributing the Stock or any portion thereof in any transaction other than a transaction exempt from
registration under the Securities Act. The Optionee further represents that the entire legal and beneficial interest of the Stock is being acquired, and will be held, for the account of the Optionee only and neither in whole nor in part for any
other person. 

  

	 	(f)	 Absence of Solicitation. The Optionee was not presented with or solicited by any form of general solicitation or general advertising, including, but
not limited to, any advertisement, article, notice, or other communication published in any 

  

 -2- 

	 	 
newspaper, magazine, or similar media, or broadcast over television, radio or similar communications media, or presented at any seminar or meeting whose
attendees have been invited by any general solicitation or general advertising. 

  

	 	(g)	Residence. The Optionee’s principal residence is located at the address indicated beneath the Optionee’s signature below. 

  

	 	(h)	Information Concerning the Company. The Optionee is aware of the Company’s business affairs and financial condition and has acquired sufficient information about
the Company to reach an informed and knowledgeable decision to acquire the Stock. The Optionee further represents and warrants that the Optionee has discussed the Company and its plans, operations and financial condition with its officers, has
received all such information as the Optionee deems necessary and appropriate to enable the Optionee to evaluate the financial risk inherent in acquiring the Stock and has received satisfactory and complete information concerning the business and
financial condition of the Company in response to all inquiries in respect thereof. 

  

	 	(i)	Capacity to Protect Interests. The Optionee has either (i) a preexisting personal or business relationship with the Company or any of its officers, directors, or
controlling persons, consisting of personal or business contacts of a nature and duration to enable the Optionee to be aware of the character, business acumen and general business and financial circumstances of the person with whom such relationship
exists, or (ii) such knowledge and experience in financial and business matters as to make the Optionee capable of evaluating the merits and risks of an investment in the Stock and to protect the Optionee’s own interests in the
transaction, or (iii) both such relationship and such knowledge and experience. 

  

	 	(j)	Reliance by the Company. The Optionee understands that the Option and any shares acquired upon exercise of the Option have not been qualified under the Corporate
Securities Law of 1968, as amended, of the State of California by reason of a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of the Optionee’s representations as expressed herein. The
Optionee understands that the Company is relying on the Optionee’s representations and warrants that the Company is entitled to rely on such representations and that such reliance is reasonable. 

  

 -3- 

	5.	Other Agreements. Optionee acknowledges and agrees that the shares received upon exercise of this Option shall be subject to the Stockholders Agreement and the transfer and
other restrictions, rights, and obligations set forth therein. By executing this Agreement, Optionee hereby becomes a party to and bound by the Stockholders Agreement as a Manager (as such term is defined in the Stockholders Agreement), without any
further action on the part of Optionee, the Company or any other person. 

  

	6.	Legends. Certificates evidencing any shares issued upon exercise of the Option granted hereby may bear the following legends, in addition to any legends which may be
required by the Stockholders Agreement: 

 “The securities represented by this certificate were issued in a private
placement, without registration under the Securities Act of 1933, as amended (the “Act”), and may not be sold, assigned, pledged, or otherwise transferred in the absence of an effective registration under the Act covering the transfer or
an opinion of counsel, satisfactory to the issuer, that registration under the Act is not required.” 
  

	7.	Withholding. No shares will be transferred pursuant to the exercise of this Option unless and until the person exercising this Option shall have remitted to the
Company an amount sufficient to satisfy any federal, state, or local withholding tax requirements, or shall have made other arrangements satisfactory to the Company with respect to such taxes. 

  

	8.	Nontransferability of Option. Except as provided by the following sentence, this Option is not transferable by the Optionee other than by will or the applicable laws of
descent and distribution, and is exercisable during the Optionee’s lifetime only by the Optionee. Subject to the Stockholders Agreement, this Option shall be transferable to the extent permitted by Rule 701 under the Securities Act of 1933, as
amended. 

  

	9.	Status Change. Upon the termination of the Optionee’s Employment, this Option shall continue or terminate, as and to the extent provided in the Plan.

  

	10.	Effect on Employment. Neither the grant of this Option, nor the issuance of shares upon exercise of this Option, shall give the Optionee any right to be retained in the
employ of the Company or its Affiliates, affect the right of the Company or its Affiliates to discharge or discipline such Optionee at any time, or affect any right of such Optionee to terminate his or her Employment at any time.

  

	11.	Indemnity. Optionee hereby indemnifies and agrees to hold the Company harmless from and against all losses, damages, liabilities and expenses (including without
limitation reasonable attorneys fees and charges) resulting from any breach of any representation, warranty, or agreement of Optionee in this Agreement or any misrepresentation of Optionee in this Agreement. 

  

 -4- 

	12.	Provisions of the Plan. This Option is subject in its entirety to the provisions of the Plan, which are incorporated herein by reference. A copy of the Plan as in effect on
the date of the grant of this Option has been furnished to the Optionee. By exercising all or any part of this Option, the Optionee agrees to be bound by the terms of the Plan and this Option. In the event of any conflict between the terms of this
Option and the Plan, the terms of this Option shall control. 

  

	13.	Definitions. The initially capitalized terms Optionee and Grant Date shall have the meanings set forth on the first page of this Agreement; initially capitalized terms not
otherwise defined herein shall have the meaning provided in the Plan and the Stockholders Agreement, and, as used herein, the following terms shall have the meanings set forth below: 

 “Affiliate” shall mean, with respect to any Person, any other Person directly or indirectly controlling, controlled by or under
common control with such Person. 
 “Person” shall mean any individual, partnership, corporation, association,
trust, joint venture, unincorporated organization or other entity. 
 “Section 409A Rollover Law” shall mean
Section 409A of the Code and guidance issued thereunder (or applicable thereto) including but not limited to Internal Revenue Service Notice 2005-1 (including Q&A 4(d)(ii) thereof), proposed Treasury Regulations in respect of
Section 409A of the Code (including Section 1.409A-1(b)(5) of such proposed regulations), Treasury Regulation Section 1.424-1 and any subsequent guidance under Section 409A of the Code. 
  

	14.	General. For purposes of this Option and any determinations to be made by the Administrator or Compensation Committee, as the case may be, hereunder, the determinations by
the Administrator or Compensation Committee, as the case may be, shall be binding upon the Optionee and any transferee. 

 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 
  

 -5- 

 IN WITNESS WHEREOF, the Company has caused this Option to be executed under its corporate seal by its
duly authorized officer. This Option shall take effect as a sealed instrument. 
  

			
	CRC HEALTH GROUP, INC.
		
	By:	 	  

	Name:	 	
	Title:	 	

 Dated: 
  

	
	Acknowledged and Agreed
	
	  

	Name:
	
	Address of Principal Residence:Rollover and Subscription Agreement between CRCA Holdings and CRC Health Group

 Exhibit 10.14 
 Execution Version 
 THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE AND ARE BEING OFFERED AND SOLD IN RELIANCE UPON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. THE SECURITIES ACQUIRED HEREUNDER ARE
SUBJECT TO RESTRICTIONS ON TRANSFER AND RESALE UNDER A STOCKHOLDERS AGREEMENT AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND OTHER APPLICABLE LAWS PURSUANT TO REGISTRATION OR EXEMPTION FROM REGISTRATION
REQUIREMENTS THEREUNDER AND UNDER SUCH STOCKHOLDERS AGREEMENT. 
 ROLLOVER & SUBSCRIPTION AGREEMENT 
 This Rollover & Subscription Agreement (this “Agreement”) is made as of February 6, 2006 among CRCA Holdings, Inc., a
Delaware corporation (the “Company”) and each of the investors in CRC Health Group, Inc. (the “Target”) listed on a signature page hereto as holding Rollover Options (each an “Option Investor” and,
collectively, the “Option Investors” or the “Investors”). 
 RECITALS 
 The Company was formed in connection with the Agreement and Plan of Merger dated as of October 8, 2005 (the “Merger Agreement”) by and
among the Target, the Company, and CRCA Merger Corporation (“MergerCo”). CRC Intermediate Holdings, Inc. (“Intermediate Holdings”) has been formed by the Company in connection with the consummation of the
transactions contemplated by the Merger Agreement (the “Transactions”). 
 The Company owns all of the common stock of
Intermediate Holdings, which owns all of the shares of MergerCo. 
 Under the Certificate of Incorporation of the Company, as amended and in
effect on the date hereof (the “Company’s Charter”), the Company is authorized to issues shares of Class A Common Stock, par value $.001 per share (“Class A Common”), and Class L Common Stock, par value $.001
per share (“Class L Common”). 
 Each of the Option Investors holds options to purchase shares of capital stock of the
Target. Immediately prior to the Closing under the Merger Agreement, the Option Investors will severally contribute a portion of such options (the “Rollover Options”) to the Company in exchange for options to purchase Units (with
each Unit consisting of 9 shares of Class A Common and 1 share of Class L Common) (the “Substitute Options” or the “Subject Securities”) of the Company. Each Option Investor is willing to contribute, and the Company
is willing to issue to such Option Investor in substitution for such Option Investor’s Rollover Options, such number of Substitute Options as permitted by Section 409A Rollover Law and as set forth on the signature page hereto of such Option
Investor, all on the terms and subject to conditions set forth herein. For all purposes hereunder “Section 409A Rollover Law” shall mean Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and
guidance issued thereunder (or applicable thereto) including but not limited to Internal Revenue Service Notice 2005-1 (including Q&A 4(d)(ii) thereof), proposed Treasury Regulations in respect of Section 409A of the Code (including Section
1.409A-1(b)(5) of such proposed regulations), Treasury Regulation Section 1.424-1 and any subsequent guidance under Section 409A of the Code. 

 It is anticipated that (i) on or before the Closing Date, the Company, the Investors, the parties hereto
and all other investors in the Common Stock will enter into a Stockholders Agreement substantially in the form attached hereto as Exhibit A (the “Stockholders Agreement”) setting forth certain agreements with respect to, among other
things, the management of the Company and transfers of its shares in various circumstances, and (ii) on the Closing Date, the Transactions will be consummated pursuant to the Merger Agreement. 
 AGREEMENT 
 In consideration of the foregoing, and the representations, warranties,
covenants and conditions set forth below, the parties hereto, intending to be legally bound, hereby agree as follows: 
 1.
Definitions. 
 1.1. Capitalized terms defined in the Merger Agreement and used but not otherwise defined in this
Agreement are used herein as so defined. 
 1.2. As used in this Agreement, the term “Subsidiary” means any
Person of which the Company (or other specified Person) owns directly or indirectly through a Subsidiary, a nominee arrangement or otherwise at least a majority of the outstanding capital stock (or other shares of beneficial interest) entitled to
vote generally or at least a majority of the partnership, joint venture or similar interests, or in which the Company (or other specified Person) is a general partner or joint venturer without limited liability. 
 2. Sale and Acquisition of Subject Securities. 
 2.1. On the terms and subject to the conditions hereof, and, notwithstanding anything else, such substitution being in accordance with Section 409A Rollover Law and the material terms of the Rollover Options,
each Option Investor agrees to contribute to the Company the number of Rollover Options (which options are hereby deemed contributed to the Company and cancelled) set forth on the signature page hereto of such Option Investor and the Company hereby
agrees to substitute for such Rollover Options, on the Closing Date, the number of Substitute Options set forth on the signature page hereto of such Option Investor. Except as permitted in Section 409A Rollover Law and except as expressly
provided in this Agreement, the terms of the Rollover Options are deemed incorporated into these Substitute Options; it being understood, that the exercise price and the number of shares may be adjusted (and have been adjusted as set forth on the
signature pages) as permitted under Section 409A Law. Each Substitute Option shall be subject to the terms of the CRC Health Group, Inc. 2002 Stock Option Plan and to the terms of any other agreement previously governing the Rollover Option for
which such Substitute Option is substituted, in each case to the extent required by Section 409A Rollover Law, and will also be governed by the Company’s 2006 Executive Incentive Plan (the “Incentive Plan”), as applicable,
and the Stockholders Agreement, in each case to the extent consistent with Section 409A Rollover Law. For all purposes of this Agreement, the Incentive Plan and the Stockholders 

  

 -2- 

 
Agreement, all determinations in respect of and interpretations of Section 409A Rollover Law shall be made by the Administrator (as defined in the
Incentive Plan) in its sole discretion. 
 2.2. The contribution and substitution of the Subject Securities will take place at
the same time and location as, and will be substantially contemporaneous with, but immediately prior to, the Closing pursuant to the Merger Agreement. If, prior to the closing hereunder, the Merger Agreement is terminated, this Agreement will
automatically terminate and be without further force and effect; provided, however, that no such termination of this Agreement will relieve any party from liability for breach hereof prior to such termination. 
 2.3. At the Closing, against delivery to the Company by each Option Investor of the Rollover Options contemplated by Section 2.1
above, the Company will deliver to each Investor option grants, as the case may be, for the Subject Securities to be acquired by such Investor, registered in the name of such Investor. 
 3. Representations and Warranties of the Company. The Company represents and warrants to each Investor, as of the date hereof and as of the
Closing Date, that: 
 3.1. The Company is duly organized, validly existing and in good standing under the laws of the State
of Delaware. The Company has made available to the Investors true and complete copies of the Company’s Charter and the By-Laws of the Company as in effect on the date hereof. Such documents will be in effect in such form on the Closing Date.

 3.2. The Company has or prior to the Closing Date will have taken all corporate action required to authorize the execution
and delivery of this Agreement and the issuance of the Subject Securities. The Company has the corporate power and authority to execute and deliver this Agreement and to perform its obligations hereunder, including issuing the Subject Securities.

 3.3. The Common Stock, when issued upon exercise of any Substitute Option in accordance with the terms thereof, will be
duly authorized, validly issued, fully paid and non-assessable. 
 3.4. Neither the Company nor any of its Subsidiaries has
conducted any material business or entered into any material transactions or incurred any material liability other than in connection with the formation of the Company, the Merger Agreement, the transactions contemplated thereby and the financing
thereof. 
 3.5. Each of the Merger Agreement, the Stockholders Agreement and this Agreement is, or at or prior to the Closing
will be, duly executed and delivered by, and a legal, valid and binding obligation of, the Company and MergerCo or such of them as are a party thereto, enforceable in accordance with its respective terms. 
 4. Representations and Warranties of the Investors. Each Investor individually (but not jointly or otherwise on behalf of any other Investor)
represents and warrants that: 
  

 -3- 

 4.1. Such Investor has full legal capacity, power and authority to execute and deliver
this Agreement and to perform its obligations hereunder. If such Investor is not a natural person, such Investor is duly organized and has duly authorized this Agreement. This Agreement has been duly executed and delivered by such Investor and is
the legal, valid and binding obligation of such Investor enforceable against it in accordance with the terms hereof. 
 4.2.
Such Investor has been advised that the Subject Securities have not been registered under the Securities Act or any state securities laws and, therefore, cannot be resold unless they are registered under the Securities Act and applicable state
securities laws or unless an exemption from such registration requirements is available. Such Investor is aware that the Company is under no obligation to effect any such registration with respect to the Subject Securities (except solely to the
extent provided in the Stockholders Agreement) or to file for or comply with any exemption from registration. 
 4.3. Such
Investor is aware that such Investor may sell, transfer or otherwise dispose of the Subject Securities to be acquired by such Investor only in a manner consistent with the Securities Act and the terms and conditions set forth in this Agreement and
in the Stockholders Agreement. 
 4.4. Such Investor (a) is purchasing the Subject Securities to be acquired by such
Investor hereunder for its own account, not as a nominee or agent and not with a view to, or for resale in connection with, the distribution thereof in violation of the Securities Act; (b) has no present intention of selling, granting any
participation in, or otherwise distributing, the Subject Securities to be acquired by such Investor and (c) is under no obligation, contractual or otherwise, to sell, transfer or pledge any Subject Securities, or grant any participation
interest in any Subject Securities, to any Person. 
 4.5. If so indicated on the signature page hereto of such Investor, such
Investor is an “accredited investor” within the meaning of Regulation D under the Securities Act. 
 4.6. Such
Investor’s financial condition is such that such Investor is able (a) to bear the economic risk of holding the Subject Securities for an indefinite period of time and (b) to incur a complete loss of such Investor’s entire
investment in such Subject Securities. 
 4.7. Such Investor has such knowledge and experience in financial and business
matters that he is capable of evaluating the risks and merits of such investment. 
 4.8. Such Investor has been afforded the
opportunity to ask questions and receive answers concerning the terms and conditions of the offering of Subject Securities and to obtain information reasonably necessary for such Investor to evaluate the offering. 
 4.9. Such Investor agrees to accept the Subject Securities in the condition they are in at the Closing based upon such Investor’s own
inspection, examination and determination with respect to such Subject Securities as to all matters, and without reliance upon any express or implied representations or warranties of any nature, whether in writing, orally or otherwise, made by or on
behalf of or imputed to the Company, MergerCo or any of their respective affiliates, except as expressly set forth herein. 
  

 -4- 

 5. Conditions to Acquisition and Sale of Subject Securities. 
 5.1. The Company’s obligation to issue and sell the Subject Securities is subject to the satisfaction of the following conditions:

 (a) all representations and warranties of each Investor contained in this Agreement will be true and correct as of the
Closing, and consummation of the subscriptions contemplated hereby will constitute a reaffirmation by each Investor that all representations and warranties of such Investor contained in this Agreement are true and correct as of the Closing;

 (b) on the Closing Date, substantially contemporaneously with the issuance and sale of the Subject Securities hereunder,
all conditions to the Company’s obligation to close under the Merger Agreement will have been satisfied or waived by the Company; and 
 (c) on or before the Closing Date, substantially contemporaneously with the issuance and sale of the Subject Securities hereunder, each Investor will have duly executed and delivered to the Company a counterpart of
the Stockholders Agreement and such other documents as the Company may reasonably request in connection with the transactions contemplated hereby. 
 5.2. Each Investor’s obligation to deliver the Rollover Options to the Company and to acquire the Subject Securities in substitution therefor is subject to the satisfaction of the following conditions:

 (a) all representations and warranties of the Company contained in this Agreement will be true and correct as of the
Closing, and consummation of the Closing will constitute a reaffirmation by the Company that all the representations and warranties of the Company contained in this Agreement are true and correct as of the Closing; and 
 (b) on the Closing Date, substantially contemporaneously with the issuance and sale of the Subject Securities hereunder, all conditions to
the Target’s obligation to close under the Merger Agreement will have been satisfied or waived by the Target. 
 (c) on
the Closing Date, substantially contemporaneously with the issuance and sale of the Subject Securities hereunder, each party other than such Investors will have duly executed and delivered to such Investors a counterpart of the Stockholders
Agreement and such other documents as such Investors may reasonably request in connection with the transactions contemplated hereby. 
 6.
Indemnities. 
 6.1. The Company will indemnify, exonerate and hold the Investors and each of their respective
partners, members, shareholders, Affiliates, directors, officers, fiduciaries, employees and agents and each of the partners, members, shareholders, affiliates, directors, officers, fiduciaries, employees and agents of each of the foregoing
(collectively, the “Indemnitees”) free and harmless from and against any and all actions, causes of action, 

  

 -5- 

 
suits, losses, liabilities and damages, and expenses in connection therewith, including without limitation reasonable attorneys’ fees and disbursements
(collectively, the “Indemnified Liabilities”), incurred by the Indemnitees or any of them as a result of, arising out of, or relating to any breach of any representation, warranty or agreement in this Agreement by the Company. If
and to the extent that the foregoing undertaking may be unenforceable for any reason, the Company hereby agrees to make the maximum contribution to the payment and satisfaction of each of such Indemnified Liabilities that is permissible under
applicable law. 
 6.2. Each Investor, severally and not jointly, will indemnify, exonerate and hold the Company harmless from
and against any and all Indemnified Liabilities as a result of, arising out of, or relating to any breach of any representation, warranty or agreement in this Agreement by such Investor. If and to the extent that the foregoing undertaking may be
unenforceable for any reason, such Investor hereby agrees to make the maximum contribution to the payment and satisfaction of each of such Indemnified Liabilities that is permissible under applicable law. 
 7. Miscellaneous. 
 7.1. Entire Agreement. This Agreement and the other agreements referred to herein set forth the entire understanding among the parties with respect to the subject matter thereof. 
 7.2. Notices. Any notices and other communications required or permitted in this Agreement will be effective if in writing and
delivered as provided in Section 12.2 of the Stockholders Agreement. 
 7.3. Amendment. 
 (a) This Agreement can be amended or modified only by an instrument in writing signed by the party against whom enforcement of such change
is sought. Notwithstanding the foregoing limitations, any written amendment approved and signed by the Company and holders of not less than a majority of the Subject Securities then outstanding and held by the Investors and their respective
affiliates (calculated on a fully exercised and converted basis) will be binding upon the Investors; provided, however, that any amendment that changes the amount of Subject Securities to be purchased by any Investor hereunder or the
amount or nature of the consideration to be paid by any Investor therefor must be approved by such Investor. 
 (b) No failure
or delay by any party in exercising any right, power or privilege hereunder will operate as a waiver thereof nor will any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or
privilege. The rights and remedies herein provided will be cumulative and not exclusive of any rights or remedies provided by law. 
 7.4. Expenses. Each of the Company, on the one hand, and the Target (on behalf of the Investors) on the other hand, shall bear its own costs and expenses in connection with or relating to the preparation, negotiation and execution of
this Agreement or the consummation of the other transactions contemplated hereby. All such costs and expenses borne by the 

  

 -6- 

 
Target on behalf of the Investors will be considered Transaction Expenses for purposes of the Merger Agreement. Each of the Company and the Investors will
bear its own costs and expenses in connection with or relating to any and all amendments, modifications, restructurings and waivers, and exercises and preservations of rights and remedies hereunder and the operations of the Company and any of its
Subsidiaries. 
 7.5. Successors; Assignment. This Agreement will bind and inure to the benefit of the parties hereto
and their respective successors, assigns, heirs and representatives. Prior to the Closing, no Investor may assign any of such Investor’s rights hereunder and, after the Closing, no Investor may assign any of such Investor’s rights
hereunder except in connection with a transfer of the Subject Securities in compliance with the terms and conditions of the Stockholders Agreement. 
 7.6. Survival. All covenants, agreements, representations and warranties made herein will survive the execution and delivery hereof and transfer of any Subject Securities. 
 7.7. Counterparts. This Agreement may be executed in any number of counterparts, each of which will be deemed an original but all
of which will together constitute one and the same instrument. 
 8. Governing Law; Disputes. 
 8.1. Governing Law. This Agreement and all claims arising in whole or in part out of, based on, or in connection with this
Agreement will be governed by and construed in accordance with the domestic substantive laws of the State of Delaware, without giving effect to any choice or conflict of law provision or rule that would cause the application of the domestic
substantive laws of any other jurisdiction. 
 8.2. Consent to Jurisdiction. Each party to this Agreement, by its
execution hereof, (a) hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the State of California for the purpose of any action, claim, cause of action or suit (in contract, tort or otherwise),
inquiry, proceeding or investigation arising out of or based upon this Agreement or relating to the subject matter hereof, (b) hereby waives to the extent not prohibited by applicable law, and agrees not to assert, and agrees not to allow any
of its subsidiaries to assert, by way of motion, as a defense or otherwise, in any such action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or
execution, that any such proceeding brought in one of the above-named courts is improper, or that this Agreement or the subject matter hereof or thereof may not be enforced in or by such court and (c) hereby agrees not to commence or maintain
any action, claim, cause of action or suit (in contract, tort or otherwise), inquiry, proceeding or investigation arising out of or based upon this Agreement or relating to the subject matter hereof or thereof other than before one of the
above-named courts nor to make any motion or take any other action seeking or intending to cause the transfer or removal of any such action, claim, cause of action or suit (in contract, tort or otherwise), inquiry, proceeding or investigation to any
court other than one of the above-named courts whether on the grounds of inconvenient forum or otherwise. Notwithstanding the foregoing, to the extent that any party hereto is or becomes a party in any litigation in 

  

 -7- 

 
connection with which it may assert indemnification rights set forth in this agreement, the court in which such litigation is being heard shall be deemed to
be included in clause (a) above. 
 8.3. Reliance. Each of the parties hereto acknowledges that he or it has been
informed by each other party that the provisions of this Section 8 constitute a material inducement upon which such party is relying and will rely in entering into this Agreement and the transactions contemplated hereby. 
 [The remainder of this page is intentionally left blank. Signatures follow.] 
  

 -8- 

 IN WITNESS WHEREOF, the parties hereto, intending to be legally bound by the
terms hereof, have caused this Agreement to be executed, under seal, as of the date first above written by their officers or other representatives thereunto duly authorized. 
  

					
	THE COMPANY:	 	CRCA HOLDINGS, INC.
			
		 	By:	 	 /s/ Chris Gordon

		 	Name:	 	Chris Gordon
		 	Title:	 	Vice President

  

 Rollover and Subscription Agreement 

			
	INVESTOR:	 	 /s/ Dr. Barry Karlin

		 	Dr. Barry Karlin
		
		 	Dollar Amount Rolled: $5,000,000
		
		 	Number of CRC Options Contributed: 4,908,631
		
		 	Substitute Options: $539.949
		
		 	Number of Units: 61,554.993
		
		 	Representing:
		
		 	        Number of A Shares: 553,994.936
		 	        Number of L Shares: 61,554.993
		
		 	Exercise Price Per Unit: $8.77
		
		 	Accredited Investor?:    Yes  x    No   ̈

  

 Rollover and Subscription Agreement 

			
	INVESTOR:	 	 /s/ Jerry Rhodes

		 	Jerry Rhodes
		
		 	Dollar Amount Rolled: $900,000
		
		 	Number of CRC Options Contributed: 883,554
		
		 	Substitute Options: $97,191
		
		 	Number of Units: 11,079.899
		
		 	Representing:
		
		 	        Number of A Shares: 99,719.089
		 	        Number of L Shares: 11,079.899
		
		 	Exercise Price Per Unit: $8.77
		
		 	Accredited Investor?:    Yes  x    No   ̈

  

 Rollover and Subscription Agreement 

			
	INVESTOR:	 	 /s/ Kevin Hogge

		 	Kevin Hogge
		
		 	Dollar Amount Rolled: $900,000
		
		 	Number of CRC Options Contributed: 883,554
		
		 	Substitute Options: $97,191
		
		 	Number of Units: 11,079.899
		
		 	Representing:
		
		 	        Number of A Shares: 99,719.089
		 	        Number of L Shares: 11,079.899
		
		 	Exercise Price Per Unit: $8.77
		
		 	Accredited Investor?:    Yes  x    No   ̈

  

 Rollover and Subscription Agreement 

			
	INVESTOR:	 	 /s/ Phil Herschman

		 	Phil Herschman
		
		 	Dollar Amount Rolled: $900,000
		
		 	Number of CRC Options Contributed: 883,554
		
		 	Substitute Options: $97,191
		
		 	Number of Units: 11,079.899
		
		 	Representing:
		
		 	        Number of A Shares: 99,719.089
		 	        Number of L Shares: 11,079.899
		
		 	Exercise Price Per Unit: $8.77
		
		 	Accredited Investor?:    Yes  x    No   ̈

  

 Rollover and Subscription Agreement 

			
	INVESTOR:	 	 /s/ Kathy Sylvia

		 	Kathy Sylvia
		
		 	Dollar Amount Rolled: $500,000
		
		 	Number of CRC Options Contributed: 490,863
		
		 	Substitute Options: $53,995
		
		 	Number of Units: 6,155.499
		
		 	Representing:
		
		 	        Number of A Shares: 55,399.494
		 	        Number of L Shares: 6,155.499
		
		 	Exercise Price Per Unit: $8.77
		
		 	Accredited Investor?:    Yes  x    No   ̈

  

 Rollover and Subscription Agreement 

			
	INVESTOR:	 	 /s/ Jay Raimondi

		 	Jay Raimondi
		
		 	Dollar Amount Rolled: $250,000
		
		 	Number of CRC Options Contributed: 245,432
		
		 	Substitute Options: $26,997
		
		 	Number of Units: 3,077.750
		
		 	Representing:
		
		 	        Number of A Shares: 27,699.747
		 	        Number of L Shares: 3,077.750
		
		 	Exercise Price Per Unit: $8.77
		
		 	Accredited Investor?:    Yes  x    No   ̈

  

 Rollover and Subscription Agreement 

			
	INVESTOR:	 	 /s/ John Lacy

		 	John Lacy
		
		 	Dollar Amount Rolled: $65,000
		
		 	Number of CRC Options Contributed: 63,812
		
		 	Substitute Options: $7,019
		
		 	Number of Units: 800.215
		
		 	Representing:
		
		 	        Number of A Shares: 7,201.934
		 	        Number of L Shares: 800.215
		
		 	Exercise Price Per Unit: $8.77
		
		 	Accredited Investor?:    Yes  x    No   ̈

  

 Rollover and Subscription Agreement 

			
	INVESTOR:	 	 /s/ Joe Procopio

		 	Joe Procopio
		
		 	Dollar Amount Rolled: $45,000
		
		 	Number of CRC Options Contributed: 44,178
		
		 	Substitute Options: $4,860
		
		 	Number of Units: 553.995
		
		 	Representing:
		
		 	        Number of A Shares: 4,985.954
		 	        Number of L Shares: 553.995
		
		 	Exercise Price Per Unit: $8.77
		
		 	Accredited Investor?:    Yes   ̈    No  x

  

 Rollover and Subscription Agreement 

			
	INVESTOR:	 	 /s/ John Peloquin

		 	John Peloquin
		
		 	Dollar Amount Rolled: $40,000
		
		 	Number of CRC Options Contributed: 39,269
		
		 	Substitute Options: $4,320
		
		 	Number of Units: 492.440
		
		 	Representing:
		
		 	        Number of A Shares: 4,431.959
		 	        Number of L Shares: 492.440
		
		 	Exercise Price Per Unit: $8.77
		
		 	Accredited Investor?:    Yes   ̈    No  x

  

 Rollover and Subscription Agreement 

			
	INVESTOR:	 	 /s/ Tom Brady

		 	Tom Brady
		
		 	Dollar Amount Rolled: $185,000
		
		 	Number of CRC Options Contributed: 181,619
		
		 	Substitute Options: $19,978
		
		 	Number of Units: 2,277.535
		
		 	Representing:
		
		 	        Number of A Shares: 20,497.813
		 	        Number of L Shares: 2,277.535
		
		 	Exercise Price Per Unit: $8.77
		
		 	Accredited Investor?:    Yes  x    No   ̈

  

 Rollover and Subscription Agreement 

			
	INVESTOR:	 	 /s/ Pamela B. Burke

		 	Pam Burke
		
		 	Dollar Amount Rolled: $125,000
		
		 	Number of CRC Options Contributed: 122,716
		
		 	Substitute Options: $13,499
		
		 	Number of Units: 1,538.875
		
		 	Representing:
		
		 	        Number of A Shares: 13,849.873
		 	        Number of L Shares: 1,538.875
		
		 	Exercise Price Per Unit: $8.77
		
		 	Accredited Investor?:    Yes  x    No   ̈

  

 Rollover and Subscription Agreement 

			
	INVESTOR:	 	 /s/ Wynn Watkins

		 	Wynn Watkins
		
		 	Dollar Amount Rolled: $125,000
		
		 	Number of CRC Options Contributed: 122,716
		
		 	Substitute Options: $13,499
		
		 	Number of Units: 1,538.875
		
		 	Representing:
		
		 	        Number of A Shares: 13,849.873
		 	        Number of L Shares: 1,538.875
		
		 	Exercise Price Per Unit: $8.77
		
		 	Accredited Investor?:    Yes  x    No   ̈

  

 Rollover and Subscription Agreement 

			
	INVESTOR:	 	 /s/ Gary P. Campanella

		 	Gary Campanella
		
		 	Dollar Amount Rolled: $40,000
		
		 	Number of CRC Options Contributed: 39,269
		
		 	Substitute Options: $4,320
		
		 	Number of Units: 492.440
		
		 	Representing:
		
		 	        Number of A Shares: 4,431.959
		 	        Number of L Shares: 492.440
		
		 	Exercise Price Per Unit: $8.77
		
		 	Accredited Investor?:    Yes   ̈    No   ̈

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}]]